Table 3.

DALYs[3,1] saved for a 100 patient-years treatment in each trial

	Population	Composite endpoint	Nonfatal stroke	Nonfatal MI	Vascular death
Group 1
EAFT	Stroke	46.96	61.46	4.32	−18.81
NASCET	Stroke	37.62	30.78	NR	6.84
CURE	CHD	21.42	2.75	10.83	7.84
Group 2
ESPS-2	Stroke	11.58	11.36	−0.15	0.38
TRITON-TIMI 38	CHD	9.17	0.01	9.75	−0.59
PROGRESS	Stroke	8.79	6.74	1.56	0.49
ESPRIT	Stroke	8.51	3.91	0.46	4.13
HOPE	Primary prevention	7.70	1.56	0.90	5.24
CARE	CHD	6.65	2.20	2.07	2.38
TASS	Stroke	5.84	6.06	NR	−0.23
Group 3
SPARCL	Stroke	4.48	2.45	1.91	0.13
TNT	CHD	4.10	1.14	1.47	1.49
CAPRIE_Stroke	Stroke	4.16	3.53	0.38	0.24
UK-TIA	Stroke	2.98	3.94	1.20	−2.16
SCOPE	Primary prevention	2.69	1.91	−0.31	1.09
Group 4
WHI	Primary prevention	−1.11	−0.60	−0.34	−0.17
WEST	Stroke	−5.53	2.09	−0.89	−6.73
WASID	Stroke	−6.47	15.38	−1.41	−20.45

NR: not reported